Home / Market Update / CureVac Planning to Produce 300-400 Million Vaccine Doses in 2021

CureVac Planning to Produce 300-400 Million Vaccine Doses in 2021

German biotech CureVac’s CEO, Franz-Werner Haas, said on Thursday that they are planning to produce 300-400 million doses of their coronavirus vaccine in 2021, as reported by Reuters.

Check Also

European Stocks Trade Flat as Markets Eye U.S. CPI, U.K. Spending Review, and China Trade Talks

European stock markets opened Wednesday in narrow ranges as investors absorbed the implications of the …